Table 1.
Baseline characteristics of study group.
| Clinical Characteristics | Study Group (n = 10) |
|---|---|
| Age: mean, range (±SD) | 62.8, 57–71 (5.7) |
| Women | 9 (90%) |
| Skin score (mRSS): mean, (±SD) | 13.1 (6.4) |
| Type of SSc | |
| lcSSc | 7 |
| dcSSc | 3 |
| Duration of the SSc, mean, range, (±SD) | 10.3, 6–22 (4.7) |
| Gastrointestinal manifestation | 6 (60%) |
| Pulmonary fibrosis | 4 (40%) |
| Cardiac involvement | 6 (60%) |
| Renal abnormalities | 1 (10%) |
| Hematological involvement | 2 (20%) |
| Acro-osteolysis (*) | 4 (11) |
| Digital ulcers | 3 (30%) |
| Calcinosis | 2 (20%) |
The outcomes are shown as a number and precent. Values are the mean, range, and ±SD. SSc—systemic sclerosis; lcSSc—limited cutaneous systemic sclerosis; dcSSc—diffuse cutaneous systemic sclerosis; mRSS—modified Rodnan skin score. * Number of fingers with acro-osteolysis.